In Vitro and in Vivo Activities of Tigecycline (GAR-936), Daptomycin, and Comparative Antimicrobial Agents Against Glycopeptide-Intermediate Staphylococcus Aureus and Other Resistant Gram-Positive Pathogens
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.46.8.2595-2601.2002
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2002
Authors
Publisher
American Society for Microbiology